AURX NUO THERAPEUTIC

-

NUO THERAPEUTIC Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

NUO THERAPEUTIC (AURX) reported a loss of $0.01 per share on revenue of $1.77 million for the . .

Nuo Therapeutics Inc. is a commercial stage medical device company pioneering edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape. Nuo Therapeutics Inc. is based in HOUSTON.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.01)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth
Reported Revenue
$1.77M
Revenue Estimate
Revenue Surprise
Revenue Growth